Strs Ohio Ovid Therapeutics Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$3.3 - $4.49 $77,880 - $105,964	-23,600 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$2.28 - $6.84 $9,120 - $27,360	4,000 Added 20.41%	23,600 $54,000
Q3 2020 Dec 14, 2020	BUY	$5.39 - $8.24 $36,652 - $56,032	6,800 Added 53.13%	19,600 $112,000
Q2 2020 Jul 23, 2020	BUY	$2.67 - $7.91 $34,176 - $101,248	12,800 New	12,800 $94,000
Q3 2019 Oct 21, 2019	SELL	$1.76 - $3.51 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$1.59 - $2.14 $17,490 - $23,540	-11,000 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$6.16 - $10.14 $46,200 - $76,050	7,500 Added 214.29%	11,000 $85,000
Q1 2018 Apr 20, 2018	BUY	$6.53 - $9.82 $13,060 - $19,640	2,000 Added 133.33%	3,500 $24,000
Q3 2017 Oct 23, 2017	BUY	$5.32 - $9.77 $7,980 - $14,655	1,500	1,500 $12,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $67.6M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.